Post-status epilepticus treatment with the cannabinoid agonist WIN 55,212-2 prevents chronic epileptic hippocampal damage in rats.
Di Maio, Roberto
Post-status epilepticus treatment with the cannabinoid agonist WIN 55,212-2 prevents chronic epileptic hippocampal damage in rats. [electronic resource] - Neurobiology of disease Jan 2015 - 356-65 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1095-953X
10.1016/j.nbd.2014.10.018 doi
Animals
Benzoxazines--pharmacology
Cannabinoid Receptor Agonists--pharmacology
Chronic Disease--prevention & control
Disease Models, Animal
Epilepsy--prevention & control
Hippocampus--drug effects
Male
Morpholines--pharmacology
Naphthalenes--pharmacology
Rats
Rats, Sprague-Dawley
Status Epilepticus--chemically induced
Post-status epilepticus treatment with the cannabinoid agonist WIN 55,212-2 prevents chronic epileptic hippocampal damage in rats. [electronic resource] - Neurobiology of disease Jan 2015 - 356-65 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1095-953X
10.1016/j.nbd.2014.10.018 doi
Animals
Benzoxazines--pharmacology
Cannabinoid Receptor Agonists--pharmacology
Chronic Disease--prevention & control
Disease Models, Animal
Epilepsy--prevention & control
Hippocampus--drug effects
Male
Morpholines--pharmacology
Naphthalenes--pharmacology
Rats
Rats, Sprague-Dawley
Status Epilepticus--chemically induced